TITLE

The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome: lBS vs healthy controls (not historical definitions)

AUTHOR(S)
Pimentel, M.
PUB. DATE
September 2008
SOURCE
Gut;Sep2008, Vol. 57 Issue 9, p1334
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to an article about the potential role of small intestinal bacterial overgrowth in irritable bowel syndrome in the 2008 issue.
ACCESSION #
34310438

 

Related Articles

  • Cholinergically Mediated Exaggeration of the Colonic Motor Response to Cholecystokinin. Mangel, Allen W. // American Journal of Gastroenterology;Feb1987, Vol. 82 Issue 2, p174 

    Presents a letter to the editor regarding the role of exaggerated sensitivity of the colon to cholecystokinin in the motility changes experienced by patients with irritable bowel syndrome.

  • When Is Adequate Relief Satisfactory or When Is Satisfactory Relief Adequate? Talley, Nicholas J.; Schoenfeld, Phil // American Journal of Gastroenterology;Dec2006, Vol. 101 Issue 12, p2886 

    A letter to the editor is presented in response a letter entitled "Adequate Relief in IBS Treatment Trials: Corrections to Errors Stated by Whitehead et al.," by Allen W. Mangel, and Sheri Fehnel in December 2006 issue.

  • Response to Dr. Allen Mangel's Letter. Whitehead, William E.; Palsson, Olafur S.; Levy, Rona L.; Feld, Andrew D.; VonKorff, Michael; Turner, Marsha // American Journal of Gastroenterology;Dec2006, Vol. 101 Issue 12, p2885 

    A response by William E. Whitehead and others to a letter to the editor about their article related to medical treatment of irritable bowel syndrome is presented.

  • Adequate Relief in IBS Treatment Trials: Corrections to Errors Stated by Whitehead et al. Mangel, Allen W.; Fehnel, Sheri // American Journal of Gastroenterology;Dec2006, Vol. 101 Issue 12, p2884 

    A letter to the editor is presented in response to the article "Reports of "Satisfactory Relief" by IBS Patients Receiving Usual Medical Care Are Confounded by Baseline Symptom Severity and Do Not Accurately Reflect Symptom Improvement," by W. E. Whitehead, O. S. Palsson, et al. in May 2006 issue.

  • The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome: lBS vs healthy controls (not historical definitions). Simrén, M.; Posserud, I.; Stotzer, P-O.; Björnsson, E. S.; Abrahamsson, H. // Gut;Sep2008, Vol. 57 Issue 9, p1335 

    A response by M. Simren and colleagues to a letter to the editor about their article on the potential role of small intestinal bacterial overgrowth in irritable bowel syndrome is presented.

  • Re: Locke et al. -- Risk Factors for Irritable Bowel Syndrome. Varner, Arthur E. // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3310 

    Presents a letter to the editor in response to the article "Risk Factors for Irritable Bowel Syndrome: Role of Analgesics and Food Sensitivities," by G. R. Locke in the 1999 issue.

  • Response to Dr. Varner. Locke III, G. R. // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3310 

    Presents a response by G. R. Locke to a letter to the editor about his article "Risk Factors for Irritable Bowel Syndrome: Role of Analgesics and Food Sensitivities" in the 1999 issue.

  • Anti-enteric Neuronal Antibodies and the Irritable Bowel Syndrome: Are They Really the Accused? Chongsrisawat, Voranush // Journal of Neurogastroenterology & Motility;2012, Vol. 18 Issue 2, p231 

    A letter to the editor is presented in response to the article "Anti-enteric neuronal antibodies and the irritable bowel syndrome," by J.D. Wood, S. Liu, D.A. Drossman, Y. Ringel and W.E. Whitehead in the January 2012 issue.

  • Postinfectious IBS. Mangel, Allen W. // American Journal of Gastroenterology;Mar2005, Vol. 100 Issue 3, p729 

    Presents a letter to the editor about the development of irritable bowel syndrome.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics